argenx SE Logo

argenx SE (ARGNF)

OTC

Currency in USD
936.00
0.00 (0.00%)

Closed

Oct 8, 2026

Day's Range

936.00
936.00

52 wk Range

712.03
1,020.00

Overview - ARGNF - argenx SE

Key Statistics

Valuation

Enterprise Value

53.39B

P/E (Trailing)

‪35.71‬

Price / Sales (TTM)

‪10.95‬

Price / Book

‪6.95‬

EV / EBITDA

‪33.10‬

Profitability

Gross Margin

‪90.42%‬

Profit Margin

‪32.26%‬

Operating Margin

‪31.99%‬

Return on Assets

‪11.63%‬

Return on Equity

‪23.63%‬

Ownership

Shares Outstanding

62.53M

Float

62.43M

Held by Insiders

‪0.0089%‬

Held by Institutions

‪48.70%‬

Price stats

Beta

‪-0.02‬

50-Day Avg

‪959.00‬

200-Day Avg

‪859.30‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

News Teaser - ARGNF - argenx SE

News & Analysis

View all news

Market Cap - ARGNF - argenx SE

Peers - ARGNF - argenx SE

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - ARGNF - argenx SE

About

argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies for severe autoimmune diseases. The company leverages its Immunology Innovation Program (IIP), a discovery engine that…

SectorHealthcare
IndustryBiotechnology
Employees1.59K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.